Zacks Investment Research on MSN
Dexcom's G7 shows strong results in type 2 diabetes CONNECT study
DexCom, Inc. DXCM recently announced that results from its CONNECT randomized controlled trial have been published in The New England Journal of Medicine. The study evaluated the benefits of its ...
The twiist Automated Insulin Delivery System is now available for adults with insulin-treated type 2 diabetes.
DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced that results from the landmark CONNECT randomized controlled trial have been published in The New England Journal ...
How big is the sensor patch market, and why is it growing so fast? The global sensor patch market is valued at USD 7.9 ...
怀俄明州谢里丹，2026年10月13日/美通社/——传感器贴片市场的规模有多大？为何其增长如此迅速？据WissenResearch的一项最新研究显示，全球传感器贴片市场在2026年的规模预计将达到79亿美元，并有望在2031年增至289亿美元；在预测 ...
Tandem Diabetes is advancing next-generation insulin delivery technology and international expansion, but competition and ...
DEXCOM, INC. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of the fifth season of Dexcom U, the company’s one-of-a-kind NIL (Name, Image and Likeness) program ...
ODYSS N1 uses AI and a camera to log meals automatically for $299, but its food recognition and calorie accuracy still need independent testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results